Fibroblast_growth_factor-_7

Category






Useful info

Fibroblast_growth_factor-_7 Brand names, Fibroblast_growth_factor-_7 Analogs

Fibroblast_growth_factor-_7 Brand Names Mixture

  • No information avaliable

    • Fibroblast_growth_factor-_7 Chemical_Formula

    C721H1142N202O204S9

    Fibroblast_growth_factor-_7 RX_link

    No information avaliable

    Fibroblast_growth_factor-_7 fda sheet

    Fibroblast_growth_factor-_7 msds (material safety sheet)

    Fibroblast_growth_factor-_7 Synthesis Reference

    No information avaliable

    Fibroblast_growth_factor-_7 Molecular Weight

    16192.7

    Fibroblast_growth_factor-_7 Melting Point

    No information avaliable

    Fibroblast_growth_factor-_7 H2O Solubility

    No information avaliable

    Fibroblast_growth_factor-_7 State

    Liquid

    Fibroblast_growth_factor-_7 LogP

    -0.650

    Fibroblast_growth_factor-_7 Dosage Forms

    Solution (IV Injection)

    Fibroblast_growth_factor-_7 Indication

    For treatment of mucositis (mouth sores)

    Fibroblast_growth_factor-_7 Pharmacology

    Used in the prevention or treatment of oral mucoscitis (mouth ulcers arising from chemotherapy), Kepivance binds to the human keratinocyte growth factor (KGF) receptor on buccal cell surfaces. Kepivance acts as both a cell growth and survival factor by stimulating epithelial cell proliferation, differentiation, and migration around the tongue and mouth. The KGF receptor is found on many tissues particularly around the tongue, esophagus, salivary gland and other gastro-intestinal tract organs.

    Fibroblast_growth_factor-_7 Absorption

    No information avaliable

    Fibroblast_growth_factor-_7 Toxicity

    No information avaliable

    Fibroblast_growth_factor-_7 Patient Information

    No information avaliable

    Fibroblast_growth_factor-_7 Organisms Affected

    Humans and other mammals